A carregar...
Influence of Rivastigmine transdermal on butyrylcholinesterase levels in patients with Alzheimer's disease
Cholinesterase inhibitors (ChE-Is) are among the main drugs approved for the treatment of Alzheimer's disease (AD). Rivastigmine in the form of a transdermal patch is an alternative delivery method, and can give greater treatment compliance. OBJECTIVES: To conduct a preliminary assessment of th...
Na minha lista:
| Publicado no: | Dement Neuropsychol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Associação de Neurologia Cognitiva e do
Comportamento
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5619047/ https://ncbi.nlm.nih.gov/pubmed/29213761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/S1980-57642011DN05040012 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|